{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:25:38Z","timestamp":1794669938361,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003220"],"award-info":[{"award-number":["82003220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Defense Biotechnology Fund for Outstanding Young Talents","award":["01-SWKJYCJJ17"],"award-info":[{"award-number":["01-SWKJYCJJ17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03182-8","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:13:55Z","timestamp":1740050035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles"],"prefix":"10.1186","volume":"23","author":[{"given":"Cheng","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengcong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maorong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"Supplement2","key":"3182_CR1","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1093\/neuonc\/noad164","volume":"26","author":"T SARATSIS A M, KNOWLES","year":"2024","unstructured":"Saratsis A M, Knowles T, Petrovic A, et al. H3K27M mutant glioma: Disease definition and biological underpinnings[J]. Neuro Oncol. 2024;26(Supplement2):S92\u2013100.","journal-title":"Neuro Oncol"},{"issue":"1","key":"3182_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41467-023-36321-6","volume":"14","author":"V TURCO","year":"2023","unstructured":"Turco V, Pfleiderer K, Hunger J, et al. T cell-independent eradication of experimental glioma by intravenous TLR7\/8-agonist-loaded nanoparticles[J]. Nat Commun. 2023;14(1):771.","journal-title":"Nat Commun"},{"key":"3182_CR3","doi-asserted-by":"crossref","unstructured":"Jiang L, Hao Y, Shao C et al. ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance[J]. J Clin Invest, 2022, 132(6).","DOI":"10.1172\/JCI143397"},{"issue":"1","key":"3182_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-022-01623-8","volume":"21","author":"F WANG","year":"2022","unstructured":"Wang F, Zhao F, Zhang L, et al. CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma[J]. Mol Cancer. 2022;21(1):153.","journal-title":"Mol Cancer"},{"issue":"10","key":"3182_CR5","doi-asserted-by":"publisher","first-page":"eabm7077","DOI":"10.1126\/sciadv.abm7077","volume":"8","author":"J KONG","year":"2022","unstructured":"Kong J, Zou R, Law GL, et al. Biomimetic multifunctional persistent luminescence nanoprobes for long-term near-infrared imaging and therapy of cerebral and cerebellar gliomas[J]. Sci Adv. 2022;8(10):eabm7077.","journal-title":"Sci Adv"},{"issue":"11","key":"3182_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","volume":"20","author":"A GRETEN T F, VILLANUEVA","year":"2023","unstructured":"Greten T F, Villanueva A, Korangy F, et al. Biomarkers for immunotherapy of hepatocellular carcinoma[J]. Nat Rev Clin Oncol. 2023;20(11):780\u201398.","journal-title":"Nat Rev Clin Oncol"},{"issue":"21","key":"3182_CR7","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G MORAD","year":"2021","unstructured":"Morad G, Helmink B A, Sharma P, et al. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade[J]. Cell. 2021;184(21):5309\u201337.","journal-title":"Cell"},{"key":"3182_CR8","doi-asserted-by":"crossref","unstructured":"Mitra A, Kumar A, Amdare N P et al. Current Landscape of Cancer Immunotherapy: harnessing the Immune Arsenal to Overcome Immune Evasion[J]. Biology, 2024, 13(5).","DOI":"10.3390\/biology13050307"},{"key":"3182_CR9","doi-asserted-by":"crossref","unstructured":"Agosti E, Zeppieri M, De Maria L et al. Glioblastoma Immunotherapy: a systematic review of the Present strategies and prospects for Advancements[J]. Int J Mol Sci, 2023, 24(20).","DOI":"10.3390\/ijms242015037"},{"issue":"5","key":"3182_CR10","doi-asserted-by":"publisher","first-page":"2055417","DOI":"10.1080\/21645515.2022.2055417","volume":"18","author":"B YUAN","year":"2022","unstructured":"Yuan B, Wang G, Tang X, et al. Immunotherapy of glioblastoma: recent advances and future prospects[J]. Hum Vaccin Immunother. 2022;18(5):2055417.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"3182_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2024.01.008","volume":"187","author":"G LEUZZI","year":"2024","unstructured":"Leuzzi G, Vasciaveo A, Taglialatela A, et al. SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion[J]. Cell. 2024;187(4):861\u2013e881832.","journal-title":"Cell"},{"issue":"18","key":"3182_CR12","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","volume":"186","author":"X CHEN","year":"2023","unstructured":"Chen X, Lu Q, Zhou H, et al. A membrane-associated MHC-I inhibitory axis for cancer immune evasion[J]. Cell. 2023;186(18):3903\u201320. e3921.","journal-title":"Cell"},{"key":"3182_CR13","doi-asserted-by":"crossref","unstructured":"Griffin G K, Wu J, Iracheta-vellve A, et al. Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity[J]. Nature. 2021;595(7866):309\u201314.","DOI":"10.1038\/s41586-021-03520-4"},{"issue":"6377","key":"3182_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.aao1710","volume":"359","author":"D PAN","year":"2018","unstructured":"Pan D, Kobayashi A, Jiang P, et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing[J]. Science. 2018;359(6377):770\u20135.","journal-title":"Science"},{"key":"3182_CR15","doi-asserted-by":"crossref","unstructured":"Wang X, Tokheim C, Gu S S, et al. In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target[J]. Cell. 2021;184(21):5357\u2013e53745322.","DOI":"10.1016\/j.cell.2021.09.006"},{"key":"3182_CR16","doi-asserted-by":"crossref","unstructured":"Manguso R T, Pope H W, Zimmer M D, et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target[J]. Nature. 2017;547(7664):413\u20138.","DOI":"10.1038\/nature23270"},{"issue":"1","key":"3182_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s40425-019-0697-7","volume":"7","author":"S PAUL","year":"2019","unstructured":"Paul S, Chhatar S, Mishra A, et al. Natural killer T cell activation increases iNOS(+)CD206(-) M1 macrophage and controls the growth of solid tumor[J]. J Immunother Cancer. 2019;7(1):208.","journal-title":"J Immunother Cancer"},{"key":"3182_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejpb.2018.05.027","volume":"129","author":"LAMPRECHTA TAMMAM S N, AZZAZY H M E","year":"2018","unstructured":"Tammam S N, Azzazy H M E Lamprechta. Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin[J]. Eur J Pharm Biopharm. 2018;129:74\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"3182_CR19","doi-asserted-by":"crossref","unstructured":"Di Polidoro A C, Cafarchio A, Vecchione D et al. Revealing Angiopep-2\/LRP1 Molecular Interaction for Optimal Delivery to Glioblastoma (GBM)[J]. Molecules, 2022, 27(19).","DOI":"10.3390\/molecules27196696"},{"key":"3182_CR20","doi-asserted-by":"crossref","unstructured":"Uhrbom L, Kastemar M, Johansson F K, et al. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis[J]. Cancer Res. 2005;65(6):2065\u20139.","DOI":"10.1158\/0008-5472.CAN-04-3588"},{"key":"3182_CR21","doi-asserted-by":"crossref","unstructured":"Ramos-casals M, Brahmer J R, Callahan M K et al. Immune-related adverse events of checkpoint inhibitors[J]. Nat Reviews Disease Primers, 2020, 6(1).","DOI":"10.1038\/s41572-020-0160-6"},{"key":"3182_CR22","doi-asserted-by":"crossref","unstructured":"Yu MW, Quail DF. Immunotherapy for glioblastoma: current progress and challenges. Front Immunol. 2021;12:676301.","DOI":"10.3389\/fimmu.2021.676301"},{"issue":"8","key":"3182_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","volume":"26","author":"R SURIBEN","year":"2020","unstructured":"Suriben R, Chen M, Higbee J, et al. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice[J]. Nat Med. 2020;26(8):1264\u201370.","journal-title":"Nat Med"},{"issue":"1","key":"3182_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H LIN","year":"2024","unstructured":"Lin H, Liu C. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives[J]. J Hematol Oncol. 2024;17(1):31.","journal-title":"J Hematol Oncol"},{"key":"3182_CR25","doi-asserted-by":"crossref","unstructured":"Wang Z, He L, Li W et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma[J]. J Immunother Cancer, 2021, 9(9).","DOI":"10.1136\/jitc-2021-002787"},{"issue":"11","key":"3182_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.tem.2021.08.011","volume":"32","author":"L ROCHETTE","year":"2021","unstructured":"Rochette L, Zeller M, Cottin Y, et al. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism[J]. Trends Endocrinol Metab. 2021;32(11):875\u201389.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"3182_CR27","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.gastro.2020.12.015","volume":"160","author":"Y MYOJIN","year":"2021","unstructured":"Myojin Y, Hikita H, Sugiyama M, et al. Hepatic stellate cells in Hepatocellular Carcinoma promote Tumor Growth Via Growth differentiation factor 15 Production[J]. Gastroenterology. 2021;160(5):1741\u2013e17541716.","journal-title":"Gastroenterology"},{"key":"3182_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pharmthera.2019.02.008","volume":"198","author":"SJ BAEK","year":"2019","unstructured":"Baek SJ, Eling T. Growth differentiation factor 15 (GDF15): a survival protein with therapeutic potential in metabolic diseases[J]. Pharmacol Ther. 2019;198:46\u201358.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"3182_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2013-08-524025","volume":"123","author":"T TANNO","year":"2014","unstructured":"Tanno T, Lim Y, Wang Q, et al. Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells[J]. Blood. 2014;123(5):725\u201333.","journal-title":"Blood"},{"key":"3182_CR30","doi-asserted-by":"crossref","unstructured":"Ratnam N M, Peterson J M, Talbert E E, et al. NF-kappaB regulates GDF-15 to suppress macrophage surveillance during early tumor development[J]. J Clin Invest. 2017;127(10):3796\u2013809.","DOI":"10.1172\/JCI91561"},{"key":"3182_CR31","doi-asserted-by":"crossref","unstructured":"Wang D, Day E A, Townsend L K, et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease[J]. Nat Rev Endocrinol. 2021;17(10):592\u2013607.","DOI":"10.1038\/s41574-021-00529-7"},{"key":"3182_CR32","doi-asserted-by":"crossref","unstructured":"Groarke JD, Crawford J, Collins S M, et al. Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design[J]. J Cachexia Sarcopenia Muscle. 2024;15(3):1054\u201361.","DOI":"10.1002\/jcsm.13435"},{"key":"3182_CR33","doi-asserted-by":"crossref","unstructured":"Albuquerque B, Chen X, Hirenallur-shanthappa D et al. Neutralization of GDF15 prevents Anorexia and Weight loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model[J]. Cells, 2022, 11(7).","DOI":"10.3390\/cells11071073"},{"key":"3182_CR34","doi-asserted-by":"crossref","unstructured":"Wang J-H, Gessler D J, Zhan W, et al. Adeno-associated virus as a delivery vector for gene therapy of human diseases[J]. Volume 9. Signal Transduction and Targeted Therapy; 2024. 1.","DOI":"10.1038\/s41392-024-01780-w"},{"key":"3182_CR35","doi-asserted-by":"crossref","unstructured":"Taghdiri M. Mussolino C. Viral and non-viral systems to deliver gene therapeutics to clinical Targets[J]. Int J Mol Sci, 2024, 25(13).","DOI":"10.3390\/ijms25137333"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03182-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03182-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03182-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:14:09Z","timestamp":1740050049000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03182-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3182"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03182-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Institutional Animal Care and Use Committee at the Air Force Medical University( IACUC-20220907 ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}